Event Carousel Image

BRINGING 

ADVANCED THERAPIES

TO MARKET.

#POWEROFPARTNERSHIPS

WE DON'T REPORT THE DAILY NEWS.

WE COLLABORATE WITH LEADING MINDS TO HELP COMMERCIALISE ADVANCED THERAPIES.

#POWEROFPARTNERSHIPS

Event Carousel Image

WE BELIEVE IN THE POWER
OF PARTNERSHIPS.

#POWEROFPARTNERSHIPS

WE WORK TOGETHER TO

IMPROVE, DISRUPT AND DRIVE

THE FUTURE OF ADVANCED

THERAPIES.

#POWEROFPARTNERSHIPS

Phacilitate Exchange

Editor's Pick

Featured content image

Cell and Gene Therapy

[WEBINAR] Is a non-viral gene editing approach the answer to developing next generation advanced therapies?

Exploring the next generation of non-viral gene-editing technologies, in partnership with Avectas
Featured content image

Cell and Gene Therapy

Innovations for Scalable Manufacturing of Allogeneic Cell Therapy Products

Allogeneic cell therapies are poised to become a new frontier for therapeutic medicines. However, reliable and scalable ... read more
Featured content image

Cell and Gene Therapy

Automation Special Interest Group: Report 2019

The 2019 Automation SIG identified some of the biggest opportunities to improve manufacturing efficiency and accuracy. T... read more

Featured Videos

Play button Featured content image

Translating Scientific and Technology Innovations from Academic Centres of Excellence to Industry

An unmissable interview with Dr Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of ... read more
Play button Featured content image

[VIDEO] Join the Advanced Therapies Revolution

The story of advanced therapies and its monumental success stories told by industry leaders

Play button Featured content image

Are We Ready for a $5m Gene Therapy?

Episode two of the Phacilitate Leaders World super plenary sessions with Dave Lennon, President of AveXis, Inc